Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester B Whitley

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
JIMD Reports|November 6, 2013
Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndromeKathleen A Delaney, Kyle R Rudser, Brianna D Yund, et al.
Molecular Genetics and Metabolism|December 26, 2013
Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndromeAlia Ahmed, Chester B Whitley, Renee Cooksley, et al.
JIMD Reports|September 10, 2019
Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study populationChristine Haller, Wenjie Song, Tricia Cimms, et al.
Molecular Genetics and Metabolism Reports|January 26, 2017
Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and IILynda E Polgreen, Alicia Kunin-Batson, Kyle Rudser, et al.
Molecular Genetics and Metabolism Reports|July 16, 2019
A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutationAlia Ahmed, Li Ou, Kyle Rudser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2025
Pegvaliase therapy for phenylketonuria: Real-world safety, efficacy, and medication access outcomes in a pharmacist-led pegvaliase programSofia Shrestha, Alicia L Zagel, Nishitha R Pillai, et al.
The Journal of Gene Medicine|January 8, 2003
Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndromeYoungtae Hong, Seung Shin Yu, Jong-Mook Kim, et al.
Molecular Genetics and Metabolism|November 25, 2011
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patientsJeanine R Jarnes Utz, Cindy Pham Lorentz, Dorothy Markowitz, et al.
The Journal of Pediatrics|April 18, 2018
Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type BChester B Whitley, Maureen Cleary, Karl Eugen Mengel, et al.
Molecular Genetics and Metabolism|February 14, 2016
Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VILynda E Polgreen, Richard K Vehe, Kyle Rudser, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
JIMD Reports|November 6, 2013
Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndromeKathleen A Delaney, Kyle R Rudser, Brianna D Yund, et al.
Molecular Genetics and Metabolism|December 26, 2013
Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndromeAlia Ahmed, Chester B Whitley, Renee Cooksley, et al.
JIMD Reports|September 10, 2019
Individual heat map assessments demonstrate vestronidase alfa treatment response in a highly heterogeneous mucopolysaccharidosis VII study populationChristine Haller, Wenjie Song, Tricia Cimms, et al.
Molecular Genetics and Metabolism Reports|January 26, 2017
Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and IILynda E Polgreen, Alicia Kunin-Batson, Kyle Rudser, et al.
Molecular Genetics and Metabolism Reports|July 16, 2019
A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutationAlia Ahmed, Li Ou, Kyle Rudser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2025
Pegvaliase therapy for phenylketonuria: Real-world safety, efficacy, and medication access outcomes in a pharmacist-led pegvaliase programSofia Shrestha, Alicia L Zagel, Nishitha R Pillai, et al.
The Journal of Gene Medicine|January 8, 2003
Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndromeYoungtae Hong, Seung Shin Yu, Jong-Mook Kim, et al.
Molecular Genetics and Metabolism|November 25, 2011
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patientsJeanine R Jarnes Utz, Cindy Pham Lorentz, Dorothy Markowitz, et al.
The Journal of Pediatrics|April 18, 2018
Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type BChester B Whitley, Maureen Cleary, Karl Eugen Mengel, et al.
Molecular Genetics and Metabolism|February 14, 2016
Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VILynda E Polgreen, Richard K Vehe, Kyle Rudser, et al.
Pageof 12